Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors | Zendy

Nils von Hentig | Zendy; Ann-Kristin Förster | Zendy; Karina Kuczka | Zendy; Ute Klinkhardt | Zendy; Stefan Klauke | Zendy; Peter Gute | Zendy; Schlomo Staszewski | Zendy; Sebastian Harder | Zendy; Jochen Graff | Zendy

Open Access

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Author(s) -

Nils von Hentig,

Ann-Kristin Förster,

Karina Kuczka,

Ute Klinkhardt,

Stefan Klauke,

Peter Gute,

Schlomo Staszewski,

Sebastian Harder,

Jochen Graff

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn333

Subject(s) - platelet , amprenavir , medicine , platelet activation , flow cytometry , saquinavir , monocyte , lopinavir , protease , immunology , pharmacology , chemistry , viral load , hiv 1 protease , human immunodeficiency virus (hiv) , antiretroviral therapy , biochemistry , enzyme

Thromboembolic complications under antiretroviral therapy (ART) have been described in the past. In particular, the influence of protease inhibitors (PIs) on platelet activation and coagulation is currently under discussion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research